|
ZNF280B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.83908444029157E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.29329991160887E-10 |
| Normal-vs-Stage2 |
4.323900E-03 |
| Normal-vs-Stage3 |
1.88027371450517E-12 |
| Normal-vs-Stage4 |
1.96564986509884E-12 |
| Stage1-vs-Stage2 |
4.043700E-02 |
| Stage1-vs-Stage3 |
1.087970E-02 |
| Stage1-vs-Stage4 |
3.6127000000441E-06 |
| Stage2-vs-Stage3 |
5.954300E-04 |
| Stage2-vs-Stage4 |
1.55963999999287E-05 |
| Stage3-vs-Stage4 |
4.685600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.18158824338843E-13 |
| Normal-vs-AfricanAmerican |
8.102100000007E-05 |
| Normal-vs-Asian |
1.15840000036727E-07 |
| Caucasian-vs-AfricanAmerican |
8.407200E-01 |
| Caucasian-vs-Asian |
9.324200E-01 |
| AfricanAmerican-vs-Asian |
8.956800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.36859999894301E-08 |
| Normal-vs-Female |
4.07919997780226E-09 |
| Male-vs-Female |
7.860800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.83020001773582E-09 |
| Normal-vs-Age(41-60Yrs) |
9.73165992235181E-12 |
| Normal-vs-Age(61-80Yrs) |
1.18570000484652E-08 |
| Normal-vs-Age(81-100Yrs) |
2.389800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.907800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.566000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.325600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.584200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.119200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.656200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.1015000041873E-08 |
| Classical-VS-Follicular |
1.019860E-04 |
| Classical-VS-Other |
5.271600E-01 |
| Classical-VS-Normal |
6.98030000467753E-09 |
| Tall-VS-Follicular |
6.08002537205721E-12 |
| Tall-VS-Other |
2.540400E-01 |
| Tall-VS-Normal |
7.7715611723761E-15 |
| Follicular-VS-Other |
8.246400E-02 |
| Follicular-VS-Normal |
1.016220E-03 |
| Other-VS-Normal |
3.640000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.31079999871653E-08 |
| Normal-vs-N1 |
2.85239998287778E-09 |
| N0-vs-N1 |
1.064040E-02 |
|
|
